The section of the Affordable Care Act, which calls for the creation of the biosimilar pathway, was recently upheld by the Supreme Court. While not as headline-worthy as the news surrounding the individual mandate, the fact that the Biologics Price Competition and Innovation Act (BPCIA) provision survived the process was significant for the biotech world.
Biologics are some of the best treatment options for serious medical conditions such as cancer, autoimmune ...
Read more...









Past 6 Months
What I’ve learned from saving physicians from suicide
Pamela Wible, MD | PhysicianDear lawmakers: This is what it’s like to be a doctor today
Matthew Moeller, MD | PhysicianIf I’m wrong about guns, can you please explain why?
Claire McCarthy, MD | PhysicianIs Chris Christie too obese to run for president?
Jeffrey Parks, MD | PhysicianPrimary care doctors may no longer be needed
Doug Olson, MD | PhysicianWalgreens moves into primary care, and it’s our own damn fault
Kevin Pho, MD | Kevin's Take